Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19

Br J Haematol. 2020 Aug;190(4):e214-e218. doi: 10.1111/bjh.17003. Epub 2020 Jul 28.
No abstract available

Keywords: COVID-19; low-molecular-weight heparin; thrombin generation assay.

Publication types

  • Clinical Trial
  • Letter
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19 / blood*
  • COVID-19 Drug Treatment*
  • Critical Illness
  • Female
  • Hemostasis*
  • Heparin, Low-Molecular-Weight / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2*
  • Thrombin / metabolism*

Substances

  • Heparin, Low-Molecular-Weight
  • Thrombin